An MTF2-containing subcomplex of Polycomb Repressive Complex 2 promotes cell cycle progression through repression of D-type cyclin expression in certain cellular contexts.

GLP-1 (glucagon-like peptide-1) discovered in the 1980s functions as a hormone derived from the proglucagon sequence and was found to have a transformative impact on the treatment of diabetes and ...

Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States Division of Health Sciences and Technology, Massachusetts Institute of ...

Glucagon-like peptide-1 (GLP-1) is a fullness hormone that helps the body regulate blood sugar, appetite and metabolism. Ozempic, Mounjaro, Wegovy and similar drugs are GLP-1 receptor agonists ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Background: Osteocalcin has attracted attention for its potential role in diabetes management. However, there has been no bibliometric assessment of scientific progress in this field. Methods: We ...

Amino acids capable of forming peptide bonds with one another serve as building blocks for larger macromolecules known as proteins. Most notably, proteins are essential for the formation of muscle ...

With glucagon-like peptide 1 (GLP-1) agonists now close to inducing weight loss at levels only seen before through surgical intervention, obesity specialists say patients on these drugs are ...